A synthetic peptide for use as a blocking control in assays to test for specificity of STARD4 antibody, Alternative Names: STARD4 control peptide, STARD4 antibody Blocking Peptide, Anti-STARD4 Blocking Peptide, StAR-related lipid transfer, START domain containing 4 Blocking Peptide, STARD4, STARD-4, STARD 4, STARD-4 Blocking Peptide, STARD 4 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
STARD4
(StAR-Related Lipid Transfer (START) Domain Containing 4 (STARD4))
Synonyme
4632419C16Rik Peptide, 9030213J02Rik Peptide, AA517649 Peptide, AW324468 Peptide, StAR related lipid transfer domain containing 4 Peptide, StAR-related lipid transfer (START) domain containing 4 Peptide, STARD4 Peptide, Stard4 Peptide
Hintergrund
Cholesterol homeostasis is regulated, at least in part, by sterol regulatory element (SRE)-binding proteins and by liver X receptors. Upon sterol depletion, LXRs are inactive and SREBPs are cleaved, after which they bind promoter SREs and activate genes involved in cholesterol biosynthesis and uptake. Sterol transport is mediated by vesicles or by soluble protein carriers, such as steroidogenic acute regulatory protein. STAR is homologous to a family of proteins containing a 200- to 210-amino acid STAR-related lipid transfer (START) domain, including STARD4.